Infection Control Industry

The global infection control market size was valued at USD 214.0 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.7% over the forecast period from 2023 to 2030. The market is primarily driven by an increasing number of surgical & clinical procedures that intensively require infection prevention. The high preference is presumed to be a consequence of positive clinical outcomes associated with using infection control. The COVID-19 pandemic has positively impacted market growth as the demand for sterilization and disinfection in hospitals and clinics, pharmaceutical, and medical device companies has increased.

According to CNBC, the manufacturing of sanitizer products witnessed rise of 60% during the pandemic in the U.S. alone. This shows the growth potential for infection control products in the coming years. An increase in outsourcing sterilization services and the introduction of advanced sterilizing solutions are further contributing to the growth of the market for infection control. One of the important growth drivers is the increasing number of government initiatives to ensure highly intensive infection prevention. Government organizations are increasingly involved in issuing guidelines to promote awareness and efficient prevention measures globally, which is expected to contribute to market growth throughout the forecast period.

Gather more insights about the market drivers, restrains and growth of the Global Infection Control market

Infection Control Market Segments Highlights:

Type Insights

Based on the type, the global infection control market is segmented into equipment, services, and consumables. The consumables segment dominated the market for infection control and accounted for the largest revenue share in 2022. The dominant share captured by consumables is predicted to be a consequence of consistent usage and the short life cycle of these products. Consumables are being extensively incorporated in disinfection, sterilization, and other control procedures and are indispensable parts of the procedures mentioned above, accounting for a larger share. Under consumables, personal protective equipment held a substantial share as of 2022.

End-use Insights

Based on end use, the global infection control market is segmented into medical device companies, hospitals, pharmaceutical companies, clinical laboratories, and others. The hospital segment dominated the market for infection control and accounted for the largest revenue share of around 40% in 2022 and is also expected to grow at the fastest CAGR of 7.4% over the forecast period from 2023 to 2030. The considerable share is majorly a result of the high probability of getting infected on hospital premises by transmitting blood-borne or respiratory pathogens. Hospital-acquired infections require rigorous control as it is one of the major challenges faced by the market. This has urged public health organizations and hospitals to adopt highly effective control systems. Also, as per research published in NCBI, 40% to 60% of hospital infections were estimated to be at surgical sites.

Regional Insights

North America dominated the infection control market and accounted for the largest revenue share of over 30% in 2022. The substantial share captured by this region is due to a good number of strategic collaborations by key companies in the market to widen their infection control capabilities and product portfolio. In addition, increasing efforts by the established companies to widen their presence across this region is responsible for the dominant share captured by North America. For instance, In January 2017, Advanced Sterilization Products launched the STERRAD 100NX System with ALLClear in the U.S. and is planning to expand its footprint into regions such as Europe, Africa, and the Middle East. In 2020, Advance Sterilization Products got 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a 15-minute time result for the STERRAD VELOCITY® Biological Indicator, which is a device used in the STERRAD System. It offers the fastest way to provide instrument sterilization for healthcare professionals.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global personal protective equipment market size was over USD 79.53 billion in 2023 and is anticipated to grow at a CAGR of 7.2% from 2024 to 2030.
• The global laboratory equipment market size was estimated at USD 28.03 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.62% from 2023 to 2030.

Key Companies & Market Share Insights

The competition is marked by the extensive implementation of collaborative strategies by major companies such as Advanced Sterilization Products, STERUS Corporation, and Cantel Medical Corporation, which accounts for their dominant market share. These players are highly focused on adopting competitive strategies such as mergers and acquisitions, new product development initiatives, and geographical expansion. For instance, in September 2020, Midmark Corp., a leading company providing dental solutions, announced the launch of the Sterilizer Data Logger and M3 Steam Sterilizer, which will bring speed, compliance, and simplicity to the processing of instruments.

Moreover, in November 2020, Applicon Biotechnology, a part of Getinge, announced the launch of AppliFlex ST, a customizable single-use bioreactor that optimizes processes and reduces labor hours in the lab. Also, companies are entering into collaborative strategies to widen infection control capabilities. For instance, in January 2021, Steris announced the acquisition of Cantel Medical, a global provider of products preventing infection and providing services to dialysis, dental, endoscopy, and life sciences customers. Similarly, 3M launched a four-hour rapid readout biological indicator for vaporized hydrogen peroxide sterilization, designed to give results in 4 hours and monitored steam sterilization loads. The product was launched to expand the company’s product portfolio.

Key Infection Control Companies:

• 3M
• Belimed AG
• O&M Halyard or its affiliates.
• Getinge Group
• ASP
• MATACHANA
• Sterigenics U.S., LLC – A Sotera Health company
• MMM Group
• Cantel Medical Corp.
• STERIS plc.
• Midmark Corporation.
• Medivators Inc
• W&H

Segments Covered in the Report

Grand View Research has segmented the global infection control market on the basis of type, end-use, and region:

Infection Control Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Equipment
  • Disinfectors
  • Sterilization Equipment
  • Others
• Services
  • Contract Sterilization
  • Infectious Waste Disposal
• Consumables

Infection Control End-use Outlook (Revenue, USD Billion, 2018 - 2030)

• Hospitals
• Medical Device Companies
• Clinical Laboratories
• Pharmaceutical Laboratories
• Others

Infection Control Regional Outlook (Revenue in USD Million, 2018 - 2030)

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Order a free sample PDF of the Infection Control Market Intelligence Study, published by Grand View Research.